ArticleLipids in health and disease2025
The role of adipose tissue in liver fat accumulation: a sex-specific analysis in an exploratory cross-sectional study.
Article in Lipids in health and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dysregulation of the AMPK-SREBP1-FASN axis in MASLD: driving a vicious cycle of lipotoxicity and metabolic-immune crosstalk.Lipids in health and disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVisceral (VAT), subcutaneous (SFT), and total body fat (FM) contribute to hepatic steatosis, yet their relative and sex-specific effects across total, regional, and site-specific levels remain unclear. We investigated associations between fat depots, standardized skinfold sites, and liver fat (LF) while adjusting for key metabolic covariates.
methodsIn this secondary data analysis of a cross-sectional study, 48 adults (50% women; 49.6 ± 20.9 y; BMI 25.7 ± 3.7 kg/m²) underwent quantitative MRI to assess VAT and LF and ultrasound-based body mapping to quantify total and regional SFT as well as standardized skinfold sites. Bioelectrical impedance analysis determined FM. Regression analyses were conducted with LF as the dependent variable, identifying and controlling for significant covariates (diabetes mellitus [DM], arterial hypertension [aHT], hypercholesterolemia [HC], physical activity, age) (partial r). The Lindeman-Merenda-Gold (LMG) method decomposed total R² into fat-specific contributions. Total fat depots were adjusted for body surface area (BSA).
resultsAll regression models examining associations with LF showed total r values ranging from 0.63 to 0.79. In men, DM was the only significant covariate (p = 0.002). Values are given as: partial r, LMG share (% of R
conclusionVAT remains pivotal for LF in both sexes, yet SFT exhibits clear sex- and region-specific relevance. Only subcutaneous fat of the upper-body and arms contributed meaningfully to liver fat. Simple skinfold assessments-particularly triceps in men-may serve as practical indicator for early risk stratification. Larger, prospective cohorts are needed to confirm these findings.
trial registrationNot applicable this study did not involve any health care intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.